advanced search

EXPERT VIEW

KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS
EXPERT VIEW
Dave Beckstoffer
KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS
The reliable performance of a wearable drug delivery device is understandably paramount, so optimising the motion solution that drives it is crucial. Dave Beckstoffer discusses how best to achieve this and ensure the best match between the motion solution and the characteristics of the specified drug or drug range.
IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES
EXPERT VIEW
Sara Dorman
IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES
Sara Dorman discusses the benefits of single-use systems, including how they help accelerate a drug product’s journey to market securely and more sustainably.
SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING
EXPERT VIEW
Jeff Lowe
SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING
 Jeff Lowe considers single-use systems and looks at their role in the future of biopharmaceutical processing.
DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY
EXPERT VIEW
Dr Yongdong Zhou
DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY
Yongdong Zhou considers the challenges of ocular gene therapy delivery approaches.
FORMULATING SUPERIOR ORAL SUSPENSIONS FOR BETTER PATIENT COMPLIANCE
EXPERT VIEW
Rina Chokshi
FORMULATING SUPERIOR ORAL SUSPENSIONS FOR BETTER PATIENT COMPLIANCE
Rina Chokshi and Dago Caceres discuss how leveraging key ingredients in oral suspensions can enhance stability and sensory attributes, as well as encourage patient compliance.
FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS
EXPERT VIEW
Dr Bernard Vrijens
FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS
Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.
HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES
EXPERT VIEW
Dr Ben Cox
HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES
Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.
HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE
EXPERT VIEW
Sylvia Kaiser
HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE
Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.
CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY
EXPERT VIEW
Gabrielle Whitworth-Smith
CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY
Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.
SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW
EXPERT VIEW
Paul Edalat
SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW
Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.
EXTRACELLULAR VESICLE ENGINEERING: OPTIMISING NATURE’S NON-IMMUNOGENIC, DRUG DELIVERY PLATFORM
EXPERT VIEW
Dr Anna Cifuentes-Rius
EXTRACELLULAR VESICLE ENGINEERING: OPTIMISING NATURE’S NON-IMMUNOGENIC, DRUG DELIVERY PLATFORM
Anna Cifuentes-Rius discusses the exciting potential of extracellular vesicles to advance drug delivery, in particular their natural ability to carry API payloads across difficult-to-traverse biological barriers.
RECENT TRENDS & DEVELOPMENTS IN INJECTABLE FORMULATION & DELIVERY
EXPERT VIEW
Dr Martin Gonzalez
RECENT TRENDS & DEVELOPMENTS IN INJECTABLE FORMULATION & DELIVERY
Martin Gonzalez details current trends in sterile injectable formulations and their delivery devices, and the challenges pharma and its contract development and manufacturing company partners face in bringing emerging breakthroughs to market.
ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?
EXPERT VIEW
Rob Udale
ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?
Rob Udale, Catriona Eldridge and Omar Shah assess the assertion that pMDIs are the most environmentally damaging of the available pulmonary drug delivery device archetypes, and explore some of the intricacies not accounted for in the public discourse surrounding pMDIs.
CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY
EXPERT VIEW
Dr Jnanadeva Bhat
CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY
Jnanadeva Bhat and Anita Solanki discuss the role that hard capsules are able to play in delivering a more sustainable pharmaceutical industry, both as an oral solid dosage form and in dry powder inhalers.
NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY
EXPERT VIEW
Frédérique Bordes-Picard
NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY
Frédérique Bordes-Picard looks at the role of nanotechnology in the nasal and pulmonary routes of drug delivery and explains how nanoparticle explains how nanoparticle solutions could transform patient comfort and compliance.
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
EXPERT VIEW
Rob Udale
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.
DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?
EXPERT VIEW
Wilbur de Kruijf
DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?
Wilbur de Kruijf and Bernhard Müllinger discuss the the market requirements for new inhalation options and the benefits of soft mist inhalers.
USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY
EXPERT VIEW
Dr Justin Lacombe
USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY
Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.
AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS
EXPERT VIEW
Dr Caterina Minelli
AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS
Caterina Minelli discusses the importance of co-operation between metrology institutes and the pharmaceutical industry in the pursuit of improving analytical techniques and standards for the characterisation of particle attributes in drug development.
EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS
EXPERT VIEW
Daniel Lock
EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS
Daniel Lock discusses the latest innovations in nebuliser technology for drug delivery to the lungs.
CAPSULES FOR DRY POWDER INHALATION – A COMPLETE PRODUCT
EXPERT VIEW
Anita Solanki
CAPSULES FOR DRY POWDER INHALATION – A COMPLETE PRODUCT
Anita Solanki, Jnanadeva Bhat and Justin Kalafat discuss capsules for dry powder formulation and consider their potential as a dosage form for patients with respiratory conditions and systemic illnesses.
WHY GENE THERAPY IS PERFECT FOR TREATING OCULAR DISEASES
EXPERT VIEW
Dr Yongdong Zhou
WHY GENE THERAPY IS PERFECT FOR TREATING OCULAR DISEASES
Yongdong Zhou discusses the applications, advantages and challenges of gene therapy in the ophthalmic sector.
ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY
EXPERT VIEW
Dr Jay S Duker
ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY
Jay S Duker discusses the history and future of ocular drug delivery, with a special focus on posterior segment diseases and the battle to overcome significant patient and caregiver burdens.
Top